This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Hepatocellular carcinoma (HCC), also known as primary liver cancer, is a cancer of the liver that originates in the liver cells. It is the most common type of liver cancer and is one of the leading causes of cancer-related deaths worldwide. HCC is typically seen in patients who have cirrhosis, a long-term condition caused by scarring of the liver due to chronic liver damage. Other risk factors for HCC include long-term infection with hepatitis B or C, diabetes, obesity, alcohol abuse, and exposure to certain toxins. HCC can cause a variety of symptoms including abdominal pain, jaundice, weight loss, and fatigue. Diagnosis of HCC is usually done by imaging tests such as CT scans, MRI scans, and ultrasound. Blood tests may also be used to screen for elevated levels of alpha-fetoprotein (AFP) and/or des-gamma-carboxy prothrombin (DCP). If HCC is suspected, a biopsy may be done to confirm the diagnosis. Treatment for HCC depends on the extent of the disease and can include surgery, radiation therapy, chemotherapy, and targeted therapies.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States